Related references
Note: Only part of the references are listed.Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial
John M. S. Bartlett et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Topoisomerase II binds importin α isoforms and exportin/CRM1 but does not shuttle between the nucleus and cytoplasm in proliferating cells
Shelagh E. L. Mirski et al.
EXPERIMENTAL CELL RESEARCH (2007)
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
Christopher J. Poole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil:: Danish Breast Cancer Cooperative Group
AS Knoop et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
G Arpino et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Human topoisomerase IIα nuclear export is mediated by two CRM-1-dependent nuclear export signals
JG Turner et al.
JOURNAL OF CELL SCIENCE (2004)
Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview
C Guillemette et al.
BREAST CANCER RESEARCH (2004)
Identification of functional nuclear export sequences in human topoisomerase IIα and β
SEL Mirski et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Expression of the HERI-4 family of receptor tyrosine kinases in breast cancer
CJ Witton et al.
JOURNAL OF PATHOLOGY (2003)
Quantitative association between, HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer
G Konecny et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Automated subcellular localization and quantification of protein expression in tissue microarrays
RL Camp et al.
NATURE MEDICINE (2002)
Dynamics of human DNA topoisomerases IIα and IIβ in living cells
MO Christensen et al.
JOURNAL OF CELL BIOLOGY (2002)
Cell cycle-coupled variation in topoisomerase IIα mRNA is regulated by the 3′-untranslated region -: Possible role of redox-sensitive protein binding in mRNA accumulation
PC Goswami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Influence of cell cycle and oncogene activity upon topoisomerase IIα expression and drug toxicity
DW Stacey et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Cell-cycle regulation of the DNA topoisomerase IIα promoter is mediated by proximal CCAAT boxes:: possible involvement of acetylation
N Adachi et al.
GENE (2000)
Share Paper
